82 studies found for:    "Thrombophilia" OR "prothrombin thrombophilia"
Show Display Options
Rank Status Study
21 Unknown  Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Condition: Cancer
Intervention:
22 Completed Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
Condition: Chest Pain
Intervention:
23 Completed Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
Condition: Deep Venous Thrombosis
Intervention:
24 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
25 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
26 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
Intervention:
27 Completed Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Conditions: Factor V Leiden;   Factor II;   Thrombosis
Intervention:
28 Recruiting Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
Conditions: High Risk Pregnant Women;   Placental Insufficiency;   Preeclampsia
Intervention: Drug: Enoxaparin
29 Completed Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
Conditions: Thromboembolism;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: coagulation study;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: physiologic testing;   Procedure: study of high risk factors
30 Unknown  Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab
31 Completed Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Conditions: Acquired Antithrombin III Deficiency;   Coronary Artery Bypass
Intervention: Drug: Antithrombin III
32 Terminated International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Conditions: Thrombotic Microangiopathy;   Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura
Intervention:
33 Active, not recruiting Ceprotin Treatment Registry
Condition: Severe Congenital Protein C Deficiency
Intervention: Biological: Protein C Concentrate (Human)
34 Terminated
Has Results
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Rituximab;   Procedure: Plasma exchange;   Drug: Corticosteroids
35 Recruiting Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Biological: rituximab
36 Recruiting Anti-thrombin III (ATIII) vs Placebo in Children (<6mo) Undergoing Open Congenital Cardiac Surgery
Condition: ATIII Deficiency
Interventions: Drug: Anti-thrombin III;   Other: Placebo
37 Completed ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention:
38 Not yet recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations
39 Recruiting Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: Danazol
40 Not yet recruiting Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Recombinant ADAMTS13

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years